Leaders with Vision and Expertise
Decades of biopharma expertise guiding companies from opportunity to lasting, meaningful outcomes.
Leadership
Albert Pat Fetaya
Partner
Most recently, Mr. Fetaya held the position with Servier of Head, US Business Development, with accountability for sourcing and assessing external growth opportunities and executing transactions. During that time, Servier’s US revenue grew from $300M to $1.6 Billion annually, primarily based on assets acquired via business development transactions.
Prior to that, he led US Business development efforts for Sun Pharmaceuticals, where he was a key member of the team that built the firm’s Specialty Pharm business via key transactions, including the acquisition of Odomzo (oncology) and the licensing of Winlevi (dermatology). During that time, the US specialty pharm business grew from initiation to $600 M annual revenue. In his previous role, he was a member of the Global Commercialization team at Bristol Myers Squibb, where he was recognized with the BMS President's Award for work in aligning Global and Regional team pre-launch efforts. Earlier in his career, he worked in Business Development at Johnson and Johnson, where he was developed growth strategies, closed over 30 transactions, and served as liaison to the Company's Asia-Pacific business development group.
He also has technology experience via a prior role in Avaya Inc’s Corporate Development group.
Mr. Fetaya obtained an honor with distinction Masters from University of Pennsylvania, concentration in Engineering (Moore School) and Business (Wharton School), an MBA in Finance from Rutgers, and a BA in Chemistry. He is an active member of the Association for Corporate Growth NJ chapter.
